145
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Incidence of hypertensive disorders of pregnancy in Romania

, , , , ORCID Icon, & show all
Pages 423-428 | Received 06 May 2020, Accepted 18 Jul 2020, Published online: 06 Aug 2020

References

  • Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–1074.
  • Say L, Chou D, Gemmill A. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
  • Ablos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
  • Lisonkova S, Sabr Y, Mayer C. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstetrics Gynecol. 2014;124(4):4:771–781.
  • Ws Cxk SG, Yang Q, Walker M. Pregnancy induced hypertension is associated with lower infant mortality in preterm singletons. BJOG. 2006;113(5):544–551.
  • Panaitescu AM, Baschat AA, Akolekar R, et al. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2017;50(3):361–366.
  • Panaitescu AM, Akolekar R, Kametas N, et al. Impaired placentation in women with chronic hypertension who develop pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):496–500.
  • de Bernis L, Kinney MV, Stones W, et al. Stillbirths: ending preventable deaths by 2030. Lancet ending preventable stillbirths series study group. Lancet. 2016 Feb 13;387(10019):703–716.
  • Bustreo F, Say L, Koblinsky M, et al. Ending preventable maternal deaths: the time is now. Lancet Glob Health. 2013 Oct;1(4):e176–7.
  • Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy (2014): A revised statement from the ISSHP. Pregnancy Hypertens. 2014;02:001.
  • Khan N, Andrade W, De Castro H, et al. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening. Ultrasound Obstet Gynecol. 2020;55(1):50–57.
  • Nicolaides KH, Wright D, Syngelaki A, et al. Fetal medicine foundation fetal and neonatal population weight charts. Ultrasound Obstet Gynecol. 2018;52(1):44–51.
  • Abalos E, Cuesta C, Carroli G, et al. WHO multicountry survey on maternal and newborn health research network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the world health organization multicountry survey on maternal and newborn health. BJOG. 2014;121(Suppl 1):14–24.
  • O’Gorman N, Wright D, Poon LC, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017 Jun;49(6):751–755.
  • European Health for all database HFA-DB. World Health Organisation, 2019.
  • Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2019;pii:S0002-9378(19)32618–3.
  • Huluta I, Panaitescu AM. Prediction of preeclampsia developing at term. Ginekol Pol. 2018;89(4):218–221.
  • Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017;1:CD009273.
  • Middleton P, Shepherd E, Crowther CA. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2018;5:CD004945.
  • Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019;394:1181–1190.
  • Panaitescu AM, Rotaru D, Ban I, et al. The prevalence of underweight, overweight and obesity in a romanian population in the first trimester of pregnancy – clinical implications Acta Endocrinol (Buchar). 2019;15(3):323–332.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
  • Stativa E, Rus AV, Suciu N, et al. Characteristics and prenatal care utilisation of Romanian pregnant women. Eur J Contracept Reprod Health Care. 2014;19(3):220–226.
  • Dorobantu M, Tautu OF, Dimulescu D, et al. Perspectives on hypertension’s prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey. J Hypertens. 2018;36(3):690–700.
  • Van Oostwaard MF, Langenveld J, Schuit E, et al. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am J Obstet Gynecol. 2015;212(5):624.e1-17.
  • Garovic VD, White WM, Vaughan L, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75(18):2323–2334.
  • Piepoli MF, Hoes AW, Agewall S, et al. ESC scientific document group. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315–2381.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.